GSK logo

GSK plc (GSK) Shareholders equity

annual shareholders equity:

$17.12B+$106.80M(+0.63%)
December 31, 2024

Summary

  • As of today (August 20, 2025), GSK annual stockholders equity is $17.12 billion, with the most recent change of +$106.80 million (+0.63%) on December 31, 2024.
  • During the last 3 years, GSK annual shareholders equity has fallen by -$3.27 billion (-16.03%).
  • GSK annual shareholders equity is now -16.03% below its all-time high of $20.39 billion, reached on December 31, 2021.

Performance

GSK Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGSKbalance sheet metrics

quarterly shareholders equity:

$20.27B+$2.00B(+10.92%)
June 30, 2025

Summary

  • As of today (August 20, 2025), GSK quarterly stockholders equity is $20.27 billion, with the most recent change of +$2.00 billion (+10.92%) on June 30, 2025.
  • Over the past year, GSK quarterly shareholders equity has increased by +$2.10 billion (+11.57%).
  • GSK quarterly shareholders equity is now -6.43% below its all-time high of $21.66 billion, reached on June 30, 2007.

Performance

GSK quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGSKbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

GSK Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+0.6%+11.6%
3 y3 years-16.0%+1.9%
5 y5 years+13.3%+20.7%

GSK Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-16.0%+34.3%at high+98.4%
5 y5-year-16.0%+34.3%-4.6%+98.4%
alltimeall time-16.0%>+9999.0%-6.4%>+9999.0%

GSK Shareholders equity History

DateAnnualQuarterly
Jun 2025
-
$20.27B(+10.9%)
Mar 2025
-
$18.27B(+6.7%)
Dec 2024
$17.12B(+0.6%)
$17.12B(-8.9%)
Sep 2024
-
$18.79B(+3.4%)
Jun 2024
-
$18.17B(+3.9%)
Mar 2024
-
$17.48B(+2.8%)
Dec 2023
$17.01B(+33.5%)
$17.01B(+6.1%)
Sep 2023
-
$16.03B(-0.7%)
Jun 2023
-
$16.13B(+10.4%)
Mar 2023
-
$14.61B(+14.6%)
Dec 2022
$12.75B(-37.5%)
$12.75B(+24.8%)
Sep 2022
-
$10.22B(-48.6%)
Jun 2022
-
$19.89B(+42.5%)
Mar 2022
-
$13.95B(-31.6%)
Dec 2021
$20.39B(+2.3%)
$20.39B(-2.0%)
Sep 2021
-
$20.80B(-2.1%)
Jun 2021
-
$21.24B(+3.6%)
Mar 2021
-
$20.51B(+2.9%)
Dec 2020
$19.94B(+32.0%)
$19.94B(+8.0%)
Sep 2020
-
$18.47B(+10.0%)
Jun 2020
-
$16.80B(+3.4%)
Mar 2020
-
$16.24B(+7.5%)
Dec 2019
$15.11B(+172.1%)
$15.11B(+4.2%)
Sep 2019
-
$14.51B(+215.4%)
Jun 2019
-
$4.60B(-12.1%)
Mar 2019
-
$5.23B(-5.8%)
Dec 2018
$5.55B(-6136.6%)
$5.55B(-4.9%)
Sep 2018
-
$5.84B(+20.2%)
Jun 2018
-
$4.86B(-5118.1%)
Mar 2018
-
-$96.79M(+5.2%)
Dec 2017
-$91.99M(-106.6%)
-$91.99M(-105.3%)
Sep 2017
-
$1.74B(+64.8%)
Jun 2017
-
$1.05B(-50.8%)
Mar 2017
-
$2.14B(+54.3%)
Dec 2016
$1.39B(-81.6%)
$1.39B(+674.8%)
Sep 2016
-
$179.26M(-76.6%)
Jun 2016
-
$767.32M(-81.0%)
Mar 2016
-
$4.04B(-46.5%)
Dec 2015
$7.54B(+13.4%)
$7.54B(-8.4%)
Sep 2015
-
$8.23B(-23.3%)
Jun 2015
-
$10.73B(-2.8%)
Mar 2015
-
$11.04B(+66.0%)
Dec 2014
$6.65B(-42.6%)
$6.65B(-18.7%)
Sep 2014
-
$8.18B(-21.8%)
Jun 2014
-
$10.46B(-5.2%)
Mar 2014
-
$11.03B(-4.8%)
Dec 2013
$11.59B(+22.9%)
$11.59B(+19.8%)
Sep 2013
-
$9.67B(-0.5%)
Jun 2013
-
$9.73B(-4.3%)
Mar 2013
-
$10.16B(+7.8%)
Dec 2012
$9.43B(-24.5%)
$9.43B(-6.0%)
Sep 2012
-
$10.03B(-9.2%)
Jun 2012
-
$11.04B(-21.1%)
Mar 2012
-
$14.00B(+12.2%)
Dec 2011
$12.48B(-10.3%)
$12.48B(+7.7%)
Sep 2011
-
$11.59B(-16.8%)
Jun 2011
-
$13.94B(-4.2%)
Mar 2011
-
$14.54B(+4.5%)
Dec 2010
$13.91B
$13.91B(-10.0%)
Sep 2010
-
$15.46B(+17.8%)
DateAnnualQuarterly
Jun 2010
-
$13.12B(-18.9%)
Mar 2010
-
$16.19B(+0.2%)
Dec 2009
$16.16B(+41.7%)
$16.16B(+8.9%)
Sep 2009
-
$14.84B(+16.8%)
Jun 2009
-
$12.71B(+10.0%)
Mar 2009
-
$11.56B(+1.3%)
Dec 2008
$11.40B(-40.3%)
$11.40B(-14.5%)
Sep 2008
-
$13.34B(-9.9%)
Jun 2008
-
$14.80B(-16.5%)
Mar 2008
-
$17.72B(-7.3%)
Dec 2007
$19.12B(+4.1%)
$19.12B(-5.0%)
Sep 2007
-
$20.13B(-7.1%)
Jun 2007
-
$21.66B(+11.2%)
Mar 2007
-
$19.49B(+6.1%)
Dec 2006
$18.37B(+46.4%)
$18.37B(+7.3%)
Sep 2006
-
$17.11B(+5.0%)
Jun 2006
-
$16.30B(+6.6%)
Mar 2006
-
$15.30B(+21.9%)
Dec 2005
$12.55B(+14.2%)
$12.55B(-0.1%)
Sep 2005
-
$12.56B(+7.0%)
Jun 2005
-
$11.74B(+12.0%)
Mar 2005
-
$10.49B(-4.6%)
Dec 2004
$10.99B(+24.1%)
$10.99B(+22.5%)
Sep 2004
-
$8.97B(+7.5%)
Jun 2004
-
$8.35B(+4.8%)
Mar 2004
-
$7.97B(-10.0%)
Dec 2003
$8.85B(+46.4%)
$8.85B(+0.9%)
Sep 2003
-
$8.77B(-31.2%)
Jun 2003
-
$12.75B(+12.3%)
Mar 2003
-
$11.35B(+87.8%)
Dec 2002
$6.05B(-9.3%)
$6.05B(-40.9%)
Sep 2002
-
$10.22B(-0.6%)
Jun 2002
-
$10.29B(-1.5%)
Mar 2002
-
$10.45B(+56.7%)
Dec 2001
$6.67B(-17.1%)
$6.67B(-46.8%)
Sep 2001
-
$12.54B(+5.2%)
Jun 2001
-
$11.92B(+5.1%)
Mar 2001
-
$11.34B(-1.4%)
Dec 2000
$8.04B(+25.7%)
$11.50B(+13.6%)
Sep 2000
-
$10.12B(+5.2%)
Jun 2000
-
$9.62B(-0.7%)
Mar 2000
-
$9.69B(+90.8%)
Dec 1999
$6.40B(+42.9%)
$5.08B(+2.6%)
Jun 1999
-
$4.95B(+10.8%)
Dec 1998
$4.48B(+48.4%)
$4.47B(+19.3%)
Jun 1998
-
$3.75B(+22.8%)
Dec 1997
$3.02B(+45.4%)
$3.05B(+46.6%)
Dec 1996
$2.08B(+1419.3%)
$2.08B(+218.0%)
Dec 1995
$136.63M(-98.2%)
-
Jun 1995
-
$654.72M(-91.5%)
Jun 1994
$7.76B(+14.1%)
$7.74B(+12.9%)
Jun 1993
$6.80B(+0.1%)
$6.86B(+1.1%)
Jun 1992
$6.80B(+30.7%)
$6.79B(+30.4%)
Jun 1991
$5.20B(+9.2%)
$5.20B(+9.3%)
Jun 1990
$4.76B(+34.1%)
$4.76B(+34.1%)
Jun 1989
$3.55B(+16.5%)
$3.55B(+16.5%)
Jun 1988
$3.05B(+30.6%)
$3.05B(+30.6%)
Jun 1987
$2.33B(+39.9%)
$2.33B(+39.9%)
Jun 1986
$1.67B(+56.0%)
$1.67B
Jun 1985
$1.07B(+17.0%)
-
Jun 1984
$913.95M
-

FAQ

  • What is GSK plc annual stockholders equity?
  • What is the all time high annual shareholders equity for GSK plc?
  • What is GSK plc annual shareholders equity year-on-year change?
  • What is GSK plc quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for GSK plc?
  • What is GSK plc quarterly shareholders equity year-on-year change?

What is GSK plc annual stockholders equity?

The current annual shareholders equity of GSK is $17.12B

What is the all time high annual shareholders equity for GSK plc?

GSK plc all-time high annual stockholders equity is $20.39B

What is GSK plc annual shareholders equity year-on-year change?

Over the past year, GSK annual stockholders equity has changed by +$106.80M (+0.63%)

What is GSK plc quarterly stockholders equity?

The current quarterly shareholders equity of GSK is $20.27B

What is the all time high quarterly shareholders equity for GSK plc?

GSK plc all-time high quarterly stockholders equity is $21.66B

What is GSK plc quarterly shareholders equity year-on-year change?

Over the past year, GSK quarterly stockholders equity has changed by +$2.10B (+11.57%)
On this page